PTC deepens layoffs as DMD drug faces loss of authorization across Europe

PTC deepens layoffs as DMD drug faces loss of authorization across Europe

Source: 
Fierce Biotech
snippet: 

PTC Therapeutics has announced that its layoffs will now go deeper and wider than previously announced as European regulators consider halting sales of the company’s Duchenne muscular dystrophy (DMD) drug.